MétaCan
Menu
Back to cohort
Record W4309115043 · doi:10.1002/rth2.12840

Hereditary thrombotic thrombocytopenic purpura: The risk for death at birth

2022· article· en· W4309115043 on OpenAlexaboutno aff
James N. George

Bibliographic record

VenueResearch and Practice in Thrombosis and Haemostasis · 2022
Typearticle
Languageen
FieldImmunology and Microbiology
TopicComplement system in diseases
Canadian institutionsnot available
Fundersnot available
KeywordsThrombotic thrombocytopenic purpuraMedicinePurpura (gastropod)Thrombocytopenic purpuraPediatricsImmunologyIntensive care medicinePlateletBiology

Abstract

fetched live from OpenAlex

Hereditary thrombotic thrombocytopenic purpura (hTTP) is a rare disorder. Patients with hTTP have insufficient plasma ADAMTS13, the enzyme required for cleavage of von Willebrand factor (VWF) after it is released by endothelial cells.1.Levy G.G. Nichols W.C. Lian E.C. et al.Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.Nature. 2001; 413: 488-494Crossref PubMed Scopus (1449) Google Scholar The result of ADAMTS13 deficiency is the circulation of ultra‐large multimers of VWF (ULVWF).2.Moake J.L. Rudy C.K. Troll J.H. et al.Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura.N Engl J Med. 1982; 307: 1432-1435Crossref PubMed Scopus (921) Google Scholar When blood flow becomes turbulent, the coiled molecules of ULVWF unwind, exposing platelet‐binding sites. Adherent platelets become activated, creating platelet aggregates attached to the long strings of ULVWF.3.Dong J.F. Moake J.L. Nolasco L. et al.ADAMTS‐13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.Blood. 2002; 100: 4033-4039Crossref PubMed Scopus (722) Google Scholar, 4.Shao B. Hoover C. Shi H. et al.Deletion of platelet CLEC‐2 decreases GPIb alpha‐mediated integrin alphaIIb‐beta3 activation and decreases thrombosis in a mouse model of thrombotic thrombocytopenia purpura.Blood. 2022; 139: 2523-2533Crossref PubMed Scopus (7) Google Scholar These ULVWF‐platelet aggregates can obstruct circulation. Newborn infants always have turbulent circulation at birth; therefore, infants with hTTP have great risk for systemic thrombosis and ischemia during the first days of their lives. Before birth, the infant receives maternal ADAMTS13. Fetal circulation bypasses the lungs because right atrial blood crosses through the foramen ovale and pulmonary arterial blood flows into the aorta through the ductus arteriosus. Immediately after birth, the umbilical cord is clamped, and the infant breathes. Pulmonary vascular resistance decreases. The foramen ovale closes. Blood flow through the ductus arteriosus reverses and begins to flow through the lungs. The ductus arteriosus flow remains bidirectional and turbulent until closure occurs.5.Jain A. Mohamed A. Kavanaugh B. et al.Cardiopulmonary adaptation during the first day of life in human neonates.J Pediatr. 2018; 200: 50-57Abstract Full Text Full Text PDF PubMed Scopus (25) Google Scholar Closure of the ductus arteriosus usually occurs within 48 hours after birth, although it may remain open for several days or longer, especially in premature infants.6.Fujimura Y. Lammle B. Tanabe S. et al.Patent ductus arteriosus generates neonatal hemolytic jaundice with thrombocytopenia in Upshaw‐Schulman syndrome.Blood Adv. 2019; 3: 3191-3195Crossref PubMed Scopus (13) Google Scholar Thus, until ductus arteriosus closure occurs, infants with hTTP are at great risk for arteriolar thrombosis, microangiopathic hemolytic anemia, and thrombocytopenia. Historically, the most important cause of severe hemolysis and hyperbilirubinemia at birth was RhD alloimmunization. Before treatment with plasma exchange treatment began a century ago, most infants with RhD alloimmunization died.7.Hart A.B. Familial icterus gravis of the newborn and its treatment.Canadian Medical Assoc J. 1925; 15: 1008-1010PubMed Google Scholar When immunization with Rho(D) immune globulin became available in 1968, severe hemolysis and hyperbilirubinemia in newborn infants became rare.8.Baskett T.F. From tragedy to triumph: Canadian connections in the management of rhesus hemolytic disease of the newborn.J Obstet Gynaecol Canada. 2019; 41: S207-S214Abstract Full Text Full Text PDF PubMed Scopus (3) Google Scholar ABO alloimmunization may now be the most common cause neonatal hemolysis and hyperbilirubinemia, but it is rarely severe.9.Thakur A.K. Ansari M.A. Mishra A. Jha S.K. Outcome of neonatal jaundice in term neonates with ABO incompatibility at a tertiary level center.Int J Contemporary Pediatrics. 2020; 7: 1973-1977Crossref Google Scholar When severe hemolysis with hyperbilirubinemia occurs soon after birth, it is often assumed that blood group alloimmunization is the cause. hTTP is rarely considered. Although hTTP can cause severe hemolysis, hyperbilirubinemia, and thrombocytopenia soon after birth, to the best of my knowledge there have been no published comparisons to distinguish hTTP from ABO alloimmunization until now. In this issue of RPTH, Liu and colleagues describe the distinguishing clinical features of infants with hTTP and ABO incompatibility.10.Liu J. Zhang Y. Li Z. et al.Early indicators of neonatal onset of hereditary thrombotic thrombocytopenic purpura.Res Pract Thromb Haemost. 2022; 6Abstract Full Text Full Text PDF Scopus (1) Google Scholar Their data document the clear differences between these two causes of neonatal hyperbilirubinemia and provide criteria for recognition of hTTP in newborn infants. Liu et al. present clinical and laboratory data of infants who were hospitalized at the Peking Union Medical College Hospital in Beijing, China, 2013–2021. Four infants had hTTP. None were correctly diagnosed during their initial neonatal hospitalization. The diagnosis of hTTP was established at ages 1–48 months, when symptoms recurred. Their data were compared to the data of 20 infants with ABO incompatibility (Table 1). The gestational age of birth for these infants with hTTP and ABO incompatibility was the same, 39 weeks (median range, 37–41 weeks). No infants died.TABLE 1Comparison of key distinguishing clinical features of hereditary TTP and ABO incompatibility from the study of Liu et al10.Liu J. Zhang Y. Li Z. et al.Early indicators of neonatal onset of hereditary thrombotic thrombocytopenic purpura.Res Pract Thromb Haemost. 2022; 6Abstract Full Text Full Text PDF Scopus (1) Google ScholarClinical featureHereditary TTP (4 infants)ABO incompatibility (20 infants)Family history2 patients each had 1 older sibling who died 2 days after birth with jaundice, hemolysisNo infant deathsJaundice onset (h)10 (5–13)69 (18–82)Bilirubin (mg/dl, maximum)24 mg/dl (38 h after birth)16 mg/dl (74 h after birth)Bilirubin response to phototherapy, IVIgaAll 20 patients with ABO incompatibility were treated only with phototherapy and IVIg. All four patients with hTTP were also treated with phototherapy and IVIg. Three patients with hTTP also had whole blood exchange transfusion; in the other patient, bilirubin decreased following platelet transfusions.020 (100%)Hemoglobin (g/dl, mean, minimum)10.616.3Platelet count (/μl, mean, minimum)17,000291,000Note: These data are from tables 1 and 3 and supplemental table 1 of Liu et al's publication.10.Liu J. Zhang Y. Li Z. et al.Early indicators of neonatal onset of hereditary thrombotic thrombocytopenic purpura.Res Pract Thromb Haemost. 2022; 6Abstract Full Text Full Text PDF Scopus (1) Google Scholara All 20 patients with ABO incompatibility were treated only with phototherapy and IVIg. All four patients with hTTP were also treated with phototherapy and IVIg. Three patients with hTTP also had whole blood exchange transfusion; in the other patient, bilirubin decreased following platelet transfusions. Open table in a new tab Note: These data are from tables 1 and 3 and supplemental table 1 of Liu et al's publication.10.Liu J. Zhang Y. Li Z. et al.Early indicators of neonatal onset of hereditary thrombotic thrombocytopenic purpura.Res Pract Thromb Haemost. 2022; 6Abstract Full Text Full Text PDF Scopus (1) Google Scholar The first distinguishing feature between these two groups of infants was their family history. Two of the four infants with hTTP had older siblings who both died without a diagnosis at age 2 days; both had severe jaundice, hemolysis, and thrombocytopenia. This is the inevitable fate of untreated newborn infants with hTTP.11.von Krogh A.S. Quist‐Paulsen P. Waage A. et al.High prevalence of hereditary thrombotic thrombocytopenic purpura in Central Norway: from clinical observations to evidence.J Thromb Haemost. 2016; 14: 73-82Abstract Full Text Full Text PDF PubMed Scopus (44) Google Scholar, 12.Hager H.B. Andersen M.T. A neonate presenting with jaundice, anemia, and thrombocytopenia.Blood. 2018; 131: 1627Crossref PubMed Scopus (8) Google Scholar, 13.Borogovac A. Reese J.A. Gupta S. George J.N. Morbidities and mortality in patients with hereditary thrombotic thrombocytopenic purpura.Blood Adv. 2022; 6: 750-759Crossref PubMed Scopus (7) Google Scholar No neonatal deaths were reported among the siblings of the 20 patients with ABO incompatibility. Increased serum bilirubin is common in healthy newborn infants. However, bilirubin levels >5 mg/dl at 24 h or >12 mg/dl at any time are probably pathological.14.Porter M.L. Dennis B.L. Hyperbilirubinemia in the term newborn.Am Fam Physician. 2002; 65: 599-606PubMed Google Scholar Among the four infants with hTTP, the bilirubin concentration was 10–23 mg/dl at 12 h. The median maximum bilirubin concentration was 24 mg/dl, occurring at 39 h. Among the 20 infants with ABO incompatibility, the median maximum bilirubin concentration was 16 mg/dl, occurring at 74 h after birth. The increased bilirubin was not only greater in patients with hTTP; it was refractory to the routine treatment with phototherapy and IVIg. All 24 infants received these two treatments; in the 20 patients with ABO incompatibility, the bilirubin concentration decreased. Bilirubin concentrations in the four patients with hTTP continued to increase until they received additional treatments. Platelet counts were dramatically decreased in the four infants with hTTP; they were normal in infants with ABO incompatibility. Anemia occurred in all four infants with hTTP and in five of the infants with ABO incompatibility. These distinguishing clinical features would seem to make the diagnosis of hTTP easily apparent. But the first criterion for any diagnosis is to consider it. Because hTTP is rare, it may be rarely considered. The current estimate of the prevalence of hTTP is 0.5–2.0 patients/106 people.15.Kremer Hovinga J.A. George J.N. Hereditary thrombotic thrombocytopenic purpura.N Engl J Med. 2019; 381: 1653-1662Crossref PubMed Scopus (56) Google Scholar Data from Norway suggest that the prevalence may be much higher, 16.7/106 people.11.von Krogh A.S. Quist‐Paulsen P. Waage A. et al.High prevalence of hereditary thrombotic thrombocytopenic purpura in Central Norway: from clinical observations to evidence.J Thromb Haemost. 2016; 14: 73-82Abstract Full Text Full Text PDF PubMed Scopus (44) Google Scholar The prevalence may be even greater because infants with hTTP may not be recognized and die within the first days after birth. Until hTTP is considered in all infants with severe hyperbilirubinemia, it will remain rare. Prompt suspicion of hTTP and treatment with plasma infusion or whole blood exchange transfusion is lifesaving; recovery is complete. Suspicion of hTTP is sufficient for initiating treatment; diagnosis of hTTP by documentation of ADAMTS13 deficiency requires several days. Early diagnosis and close follow‐up of infants with hTTP would prevent the recurrences that occurred in the four patients reported by Liu et al.10.Liu J. Zhang Y. Li Z. et al.Early indicators of neonatal onset of hereditary thrombotic thrombocytopenic purpura.Res Pract Thromb Haemost. 2022; 6Abstract Full Text Full Text PDF Scopus (1) Google Scholar Neonatal intensive care is a unique specialty. Hematologists, even pediatric hematologists, may not become involved in the care of newborn infants with severe thrombocytopenia. Therefore, I ask all hematologists who read the report of Liu et al10.Liu J. Zhang Y. Li Z. et al.Early indicators of neonatal onset of hereditary thrombotic thrombocytopenic purpura.Res Pract Thromb Haemost. 2022; 6Abstract Full Text Full Text PDF Scopus (1) Google Scholar to share it with their colleagues in neonatal intensive care units. hTTP may not be as rare as we think it is. I have no conflicts with the content of this Commentary.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.005
metaresearch head score (Gemma)0.002
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesScience and technology studies, Insufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.081
Threshold uncertainty score0.999

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0050.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0030.000
Scholarly communication0.0000.000
Open science0.0000.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.197
GPT teacher head0.426
Teacher spread0.229 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueResearch and Practice in Thrombosis and HaemostasisSame topicComplement system in diseasesFrench-language works237,207